Chair: James Carpenter, School of Hygiene and Tropical Medicine
Speaker: Ying Yuan, Department of Biostatistics, University of Texas
A Bayesian dose finding design for oncology clinical trials of combinational biological agents
Co-authors: Chunyan Cai, Yuan Ji;
Journal of the Royal Statistical Society: Series C (Applied Statistics), Volume 63, Issue 1, Pages 159–173, January 2014 Abstract | Paper+ | Slides
Speaker: Michael J Sweeting, Department of Public Health and Primary Care, University of Cambridge
Escalation strategies for combination therapy Phase I trials
Co-author: Adrian P Mander;
Pharmaceutical Statistics, Volume 11, Issue 3, Pages 258–266, May/June 2012 Abstract | Paper+ | Slides
Discussant: Tony Sabin, Amgen + Papers available to view from March 25th 2014 to April 22nd 2014.
For a flier advertising the event, please click here.
Joint PSI, EFSPI & ASA BIOP Webinar: Estimands
PSI, the European Federation of Statisticians in the Pharmaceutical Industry (EFSPI) and the Biopharmaceutical Section of the American Statistical Association (ASA) are jointly organising a webinar on Estimands in Practice. Speakers from regulatory authorities (FDA and EMA) and industry will present on their experience on this topic to date.
Discover your potential by working as a Covance Senior Principal / Principal Biostatistician. You'll enjoy a varied role working for different sponsors across several therapeutic areas, leading projects and mentoring junior members of the department.
Biometrics at AstraZeneca provides the data that influences decisions on how we roll back the frontiers of science to bring life-changing medicines to the world. We are at the heart of design, analytics and interpretation of AstraZeneca’s portfolio.